VCM
IBB icon

Virtue Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Virtue Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54,595
Closed -$8.84M – 361
2026
Q1 		$8.84M Buy
54,595
+1,181
+2% +$202K 1.34% 15
2025
Q4 		$9.03M Buy
+53,414
New +$8.68M 1.39% 15
2023
Q4 		– Sell
-1,725
Closed -$219K – 397
2023
Q3 		$219K Hold
1,725
– – 0.04% 363
2023
Q2 		$219K Sell
1,725
-8,328
-83% -$1.08M 0.04% 360
2023
Q1 		$1.29M Buy
+10,053
New +$1.32M 0.21% 78
2022
Q2 		– Sell
-8,709
Closed -$1.14M – 339
2022
Q1 		$1.14M Buy
8,709
+971
+13% +$126K 0.18% 140
2021
Q4 		$1.18M Sell
7,738
-2,983
-28% -$462K 0.17% 157
2021
Q3 		$1.73M Buy
10,721
+332
+3% +$55.9K 0.31% 71
2021
Q2 		$1.7M Buy
10,389
+3,150
+44% +$485K 0.34% 65
2021
Q1 		$1.09M Sell
7,239
-227
-3% -$36.1K 0.26% 121
2020
Q4 		$1.13M Buy
7,466
+2,957
+66% +$423K 0.28% 112
2020
Q3 		$611K Buy
+4,509
New +$612K 0.15% 185

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Virtue Capital Management's IBB Position: Q2 2026 in Review

Virtue Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 54,595 shares — an estimated $8.84M sold.

Virtue Capital Management first reported a position in IBB in Q3 2020 and held it in 12 quarters. The position peaked at $9.03M in Q4 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Virtue Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Virtue Capital Management sold 54,595 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.84M.
  • Virtue Capital Management first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 12 quarters.
  • Virtue Capital Management's iShares Biotechnology ETF position peaked at $9.03M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.